Covered recipient · General Payments record
KANAPORN TEMRUTRYNIT
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$549.50
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $487.44 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $304.61 | 10 |
| Nevro Corp. | $98.57 | 1 |
| Amgen Inc. | $42.41 | 2 |
| Lilly USA, LLC | $23.94 | 1 |
| PFIZER INC. | $17.91 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $20.34 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117397168 | CMS |
| Amgen Inc. | $22.07 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117397170 | CMS |
| Lilly USA, LLC | $23.94 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135093125 | CMS |
| Nevro Corp. | $98.57 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130774809 | CMS |
| Novo Nordisk Inc | $20.70 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097836041 | CMS |
| Novo Nordisk Inc | $15.13 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096910313 | CMS |
| Novo Nordisk Inc | $17.23 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097670437 | CMS |
| Novo Nordisk Inc | $121.85 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097383226 | CMS |
| Novo Nordisk Inc | $21.29 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097140136 | CMS |
| Novo Nordisk Inc | $16.85 | 06/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097818712 | CMS |
| Novo Nordisk Inc | $16.70 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096991203 | CMS |
| Novo Nordisk Inc | $17.59 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097764194 | CMS |
| Novo Nordisk Inc | $27.99 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097577013 | CMS |
| Novo Nordisk Inc | $29.28 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097584381 | CMS |
| PFIZER INC. | $17.91 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132122590 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.